TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/25 18:46 | 7/15/25 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Eisner Mark | CA | O | EVP,Chie | S.m | -57 | 5.47 | 0 | -10 | -9 | 105 | D | ||||||||||||||
6/9/23 19:12 | 6/7/23 | FGEN | Fibrogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Eisner Mark | CA | O | EVP,Chie | S | -35 | 17.04 | 0 | -2 | -1 | 163 | D | ||||||||||||||
6/5/23 16:22 | 6/2/23 | FGEN | Fibrogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Eisner Mark | CA | O | EVP,Chie | S | -21 | 18.83 | 0 | -1 | -1 | 165 | D | ||||||||||||||
4/6/23 16:32 | 4/4/23 | FGEN | Fibrogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Eisner Mark | CA | O | Chief Me | S | -172 | 18.78 | 0 | -9 | -5 | 166 | D | ||||||||||||||
3/10/23 21:55 | 3/8/23 | FGEN | Fibrogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Eisner Mark | CA | O | Chief Me | S.m | -361 | 20.60 | 0 | -18 | -9 | 175 | D | ||||||||||||||
3/6/23 16:59 | 3/2/23 | FGEN | Fibrogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Eisner Mark | CA | O | Chief Me | S | -26 | 21.87 | 0 | -1 | -1 | 172 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |